Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.
Name:
s41467-018-03224-w.pdf
Size:
3.939Mb
Format:
PDF
Description:
Full text, Open Access article
Authors
Cooks, TPateras, I
Jenkins, L
Patel, K
Robles, A
Morris, J
Forshew, T
Appella, E
Gorgoulis, Vassilis G
Harris, C
Affiliation
Laboratory of Human Carcinogenesis, NCI-CCR, National Institutes of Health, Bethesda, 20892-4258, MD, USAIssue Date
2018
Metadata
Show full item recordAbstract
TP53 mutants (mutp53) are involved in the pathogenesis of most human cancers. Specific mutp53 proteins gain oncogenic functions (GOFs) distinct from the tumor suppressor activity of the wild-type protein. Tumor-associated macrophages (TAMs), a hallmark of solid tumors, are typically correlated with poor prognosis. Here, we report a non-cell-autonomous mechanism, whereby human mutp53 cancer cells reprogram macrophages to a tumor supportive and anti-inflammatory state. The colon cancer cells harboring GOF mutp53 selectively shed miR-1246-enriched exosomes. Uptake of these exosomes by neighboring macrophages triggers their miR-1246-dependent reprogramming into a cancer-promoting state. Mutp53-reprogammed TAMs favor anti-inflammatory immunosuppression with increased activity of TGF-β. These findings, associated with poor survival in colon cancer patients, strongly support a microenvironmental GOF role for mutp53 in actively engaging the immune system to promote cancer progression and metastasis.Citation
Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246. 2018, 9(1): 771 Nat CommunJournal
Nature CommunicationsDOI
10.1038/s41467-018-03224-wPubMed ID
29472616Type
ArticleLanguage
enISSN
2041-1723ae974a485f413a2113503eed53cd6c53
10.1038/s41467-018-03224-w
Scopus Count
Collections
Related articles
- Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression.
- Authors: Yoshii S, Hayashi Y, Iijima H, Inoue T, Kimura K, Sakatani A, Nagai K, Fujinaga T, Hiyama S, Kodama T, Shinzaki S, Tsujii Y, Watabe K, Takehara T
- Issue date: 2019 Aug
- Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome.
- Authors: Zhang Y, Hu Y, Fang JY, Xu J
- Issue date: 2016 Mar 8
- BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function.
- Authors: Yue X, Zhao Y, Liu J, Zhang C, Yu H, Wang J, Zheng T, Liu L, Li J, Feng Z, Hu W
- Issue date: 2015 Aug 13
- The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
- Authors: Wei S, Wang H, Lu C, Malmut S, Zhang J, Ren S, Yu G, Wang W, Tang DD, Yan C
- Issue date: 2014 Mar 28
- Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction.
- Authors: Tran TQ, Lowman XH, Reid MA, Mendez-Dorantes C, Pan M, Yang Y, Kong M
- Issue date: 2017 Apr 6